•

0
00 U.>

0.
O

Cr

• P
0_
aA

U.,
pnouniew enuew:Aqpasykav
ct,

3
0

D4
8.
-a
.60

O D.,
>

o
>

F
0
O

00
n
SUMMARYOFPRODUCT CHARACTERISTICS
NAMEOFTHE MEDICINALPRODUCT
Gemcitabin Ebewe 10mg/ml concentrate forsolution for infusion

s•
0 _
o

co
Ln
0
a9
QUALITATIVE AND QUANTITATIVECOMPOSITION
a-
E

▪0.
0•

0.

0.
3. so

0
0
3

er

0
-
00 =
8

0
0
5
co

N
8

ma

it)
4
CD
g-
0

Each vial contains 10 mg/ml gemcitabine(as hydrochloride).

9.
a
0
Each 100ml vial contains 1000 mggemcitabine(as hydrochloride).

tJ
A
Posologyandmethodof administration

0 0

0.
5.

a.
Fo. er

‘z
0

0
B
P

0
C

0
-0

CO
.
o

4
'"C

0
0
0
b

daativo oyvadoupd
21/lowspulC IZ1IllIglouls0

cr
g

CD
'1V311013
SIIV111311.11V4I
stiopumpm altnadtuatu,
 = 0 00 t•
.1:1 '-', CD CL n n
o ? .:- .15c.. Q (P., f:t.bo0 sto n .7.,,5<' s' 4 = 0 -3 -3 .,,3- 6.1=
.O .,:.
.c• -0• -. 5 3
.8.
to E.
. e, 5a 6
,.,A•
c7
-0
.-. 0
5' n, c'
1:3 c< = 0-
c 0 -• CD
.,
0 o
0 0, 0
9 5 E4.=3•(-)
' . 0 0. 5' 0 0 It .
.) 3 i
r-7 ' ,-.x qet, 0, 0. e. a 0 g a
g. S.:
a6. . a iit. _• • . 27 5' . -, g 8 5 M.
O =
, ....
0 o
o n) A 9.
c*, ^-• >C ,14 ''' ' :4 • ...* = aa -
70 7- = 5 Cf a.
cg tQ- 5 g 5'
A, 0 0. 3
S .:3 'i
7
0. -
CD 6 sa o 5
8. 0 Q 0 R ....• c.r.'-g 'A 0 a 0
.... .,..; '.....' 0 . R, ao• P E. O C. 2
'ts
,< 9,
CO
-0 g c). t...2 0 3 0 0.,
O ...-,
-..
,--, 0 0- q 0
m 0
CD
CO
N
a• 0 a. a
. a O
5 13 0 co 0 E•_, 2 8 ., 0.
10 2 c 0
,.., 0 0. ,• 0i' 2. 1,3, 1
,..g 5
, 6 o- 6 cm --= CT 0 x. 2. a 8- g g"
F.• 2 3 ar 0 0 2
..< --... .-. a F. o. ,,..
co 5 • a co C. CD CM
o ,7,'
q C) = a) P.. 9 =. * S .3. 4 cn
00 0
n CD g - .-4: ,;- 0.
X
-g , •-• O. g
0
0 O
N
A, .'''
‘< "" 70
3 0 = •-.5
x 7 0 70
10 70 ° CD
5..'
5
• CL CC 00 0 o co 0 * 5 0
0ga
(0- -,. a 0
0-
a. qs. ," a- c m a.
vo CL. .

E. -...S5 g A 2 ,-.3 o 6
a
g „, ... 5 0 0- e°
g
CD 0 ‘.< cr.
=-a -0 0 ,,,-
cr -z •0 ,...,t . ,.., 5 a. F. 5. 0
ii. 2
.
cr s.
0 5'
-. 8
.0
o- 5
0
..,, •▪..... g9 5 o 0. 0 .< n.
9 a 4. p-r • a ,(..D.
....)

(/' n __ -- a.
0 a 6-' -§: a F,, 0 ts.) • .- CD Q
O
1)-
0

- Dr<0 its iv% . 1- ,,, -0

ic c• 0 v.,• • 0 ,...
,+ 0 5'
0- • 8 A° 0 0, o a+
ar 5.
g 0 8 '< e,-•• " 0 7 CD C> "..• 0 .I" 3
C 5 i..)
CL 19 -o 0 5 S
7 0

•O = 0
- g D.)
5 P no
I•
c• .(1- ...- co. K0
O
5. CD
a Cr
w
8- co
x .-'
m
a- 5. o.
s n ...
0 ar cr .....tta < - c. co ....5. .-c 0-
60 5-
co CD PI
0
7
`-‘1, ;•. c,0--• ,') '<
- i..., 0
0 0-a g scr
• 5 •8 0 < q ...) ••,.., ro
0 Ore
" ° S.
5. cm a. S f.„ °0 0'
•. =. (...4
5 t:j 8
Q, * .
02B mI.
cT c
'Mn
ma P 4 2-
. cr `g ? - ..4 1:1
I
.0g
0 ',2 .
ro
.
•<
(17u)
pr. '
8 5.
o-
c`
-5
A"
i., Q.co -, ..• 0 3
g . s. R
• 0 .4
6 o g a, CD 00 S '-' •-" CU
t< 7 0 a. c 0.
a R x0 ,..%) ig 7 i
g = c cr
ts. col O o.• 0
0
0 .... 0
Di " 7 CD
0 3
•a0 5 0 0 8 r°
(..,,-,..., ......
-8
m. f."?.. a g
coH 8.• 0<CD CU
.0• 2 a, - 8 @6 -0 ,.• 0 0g
-o
N' 8 00 0
co 0 f-•
.,.) a
0- cA `s' 0.
Cr 5: • 3 co t`' g „,, 5 ..<cr• a9 5.
P.'
acs;
C g c-
s.
co
... ..,
(9. 6 " "'--
;...
-:,
..... 5 g 5 ci g.
o.< 0 c- 0 8. R-

o o -0 5 21, 0 cr 0 -0
Avi :,..
V o o0

Dosemodif ication duetonon haematological toxicity

cancer,given inmonoth - -•:r incombinationwithIsplatin
Dosemodificationof _•c* :

8 -s.0 0 - ! 1 g
4a 8 4. 9
e,•'
0 ,„ 5 "
Absolutegranulocytecount ' - l 4:

0 .4_ a. - co .0 = co c
8 .0, 0 -, , 3. 8 4 0. 0. g 7, a:
0, 4 Er g -o
r'
C 0
0 0.
8
- Z ,5.?,' 03
5
(x 106/1)

-cr '..0 = w = R.
0 0 0 0 -- •
00
- •-,
c .

A, (0.
8 t• c
3. a. •-•
9 -sr E1
> r)* 5' -?'
0 ,..,- .
K g IA crci 0 E. .
• F.:., ...7 ..
0. a 0 ;7 g
N 0.0o
k"
.- :-'3:...! .• p,
g• L'.). z
< . -, 0
E. ,..0 0. co ‘.t. 2 ,7,
CD 0 0
7 • ..'7 g . '7.‹. 5.

-, 0
:Mewithin4cyle for bladdafeancer, NSCLCandpancreatic

< S.

0 ox
s•'r°
o w
0 0 ,1 g.
R -o x•00a
— .7__.,-- -

S0 5 0 CD7,. . cy
hOs' . . 5 g-
i.n . = n-
P
c› V 0
Cr 7 a O 01
< 50,000

70 = "
° < .<
(x 106/1)

8 -
:.

2 " 6
p s
Ito

OQ
8 8 5
N
..... ,..)5 0 0 •0 0
:

0.
c, P P -.,o s.
--.) go 0
. a. A= c'" 0.•
ep 0
nt

0, O 0 5
I.. 0
-. ''= -0 0 5• a .0 •0
0 . - - 0 -•
• 0
a 5 ii DO 0 Fi- 0
il-' -0 og, 0 a,
• a •.<
8
i.up.toaue pauuvad aq

g .E. O.
Percentageofstandard dose

•-, s• .0 S c; .
- g
,..
o- o 0

co no 5' '' fro 5' 5

Gemcitabine(%)

C7 CD 7 CD •-t 7 0
..... n co 5 0, 0 7
Omit dose*

X .-• 5 g 0)
-••••1 ^-• C7
Ss AD .,
of

Al
0 a FD CD 3
U
0 ...... 0. aa-5a
E -0 a (.12ci 5) 4' Q.
P 3
co. e ,,,
0-
7
g ....
4' 20.
'7 7 g 0 t..., &D 0.
0
aqi of

CD 0
s0 ....0 a-; c.i: -0 CD
2 o co
 r
A V

carboplatin
A --1 .-• IV

Dosemodi ficationof gemcitab'

pacl i taxel
Dosemodificationof gemcitabinewithinacycle for breastcancer,given incombinationwith
..-.. 3-. 4 8 -, ,_.

Absolutegranulocytecot

Absolutegranulocytecount
-rt 8 • c>, 1....,
§ 0
0 A . 0
-. A C'
8•1,,
-
c.

(x106/I)

(x106/I)
O
0 2 B 2,
0.

0. g
0.

t
Ad

000`5L<
'thina
co

Plateletcount
Ei

000'05>
IV

(x106/I)
'E.
4.8 .-.
• co
VII
8 c, 9
. --.... 8 .47;1

-
o

rovaria
..-• 17,
, - c:,
co
4t.
....c, a
•4 •

cer,given incombinationwith
a

Percentageofstandarddose
Percentageof standard dose
of Gemcitabine(%)

of Gemcitabinc(%)
Omit dose*

Omit dose*
...- s, ....
50

-4
8 E=9 t./1 8

11) 0 0
set! auwtouiao

uollaasuniupv fo potion

.s.,
For instructionsonreconstitution,seesection 6.6

DosemodOcations dueto haematologicaltoxicity insubsequentcycles,for all indications

• Ye
O
5 C g
0 5 °
a oo
g g g
S1100101.1pUT A UOD

`e
0 E
: g .. 2
CD .--. 5 Z'
' :r
.... U-
§. 0.
5 §,,..
N
.
8' a F =. a
c ii cra
- go
47 A 2
• C 6
, ,..., q • . , I, =.
0 " ogaRo m
i- go
8 -a c ac ,, , ‘,,.,,
g <0 , 0 0
co 0 a 0 3"
to 0 CD X 3'4 '4 u
- a a 2
CD ' ._. _ 12.•
?,
- g g
7. CD 0. •
Ft
(0 c
A A ?;g
2 a. h- 0 0 a g
0. Q O. 0 0
g to!, XX n 0.
ir% = Is, • g
.-. .... . 5'
v‘42' • a ti
3 a -.4
2 a cs iT -,o o
o •-* *O.°
-, -, co
‹. a o a
0 . o
-, o
0. R
1
°
7 5 5. g.
g g oo.
a4 C' ,...) vi 0
zo
8 0. 0..
pnew yew ehuew:AcipasviaN

so ,..c
o -9,
oo x
N
5'
0
co co
ry g. 5:
1-75'
S. g 5'
• CL• a =
0.
"a a 0
O
5' O ro
P co. 5.
G
r 5-,
CSi °S. g co
0
03 5' C(1
 r c g > 10 o 5o n o ta 7 5 m ..,.. C)

Actenmowei iiminuoouoD
2 OICUSI2A2110p2ISOd
Reportsof posteriorreversibleen

Xpoixot inaPolomtuagH
0 ana. P.., o a o= 05. ' 1 :7
..... .0"; CED
.5 0. 0,,, 5 a- a g g4, ..,
gr ..., o 5. p., a 0.
* 7 ,‹ 3. - a 7,' co'• cr o
0, a 0,0 a-
. a., .!,''•
§.. _ ,..„.
8 ,0 Cr .....
O. ,5 g .,.=. g p, g.
,R t . s' ''' 0 0 0 ‘.4. 5.
a
cr S - a• C C. 0 0 c
"1:3
.-,.
0 CD
.e to '8 cr E 8 0 C'. .0
R 0 0 a05. 0. ii• s. g c0 CD 0
0
.8' o .--,, - ,r.s,
0.
2 ' a
..
a oo
`6' :.. g
-• 04 oo
20
0 c -a 5 CA
...
a ..., g -0
5 5
° g. ••
„, .0.,..•• "ff
cr _ ,,,, a. cfg ,1 g• 4
3 a -2 1g g• sa
et ma
72 a - 5. 63 . --6. * o
8. 5
,;* Tt n .0 Ft
;2 _.
o o 5 c''
e. • , n = -• =
cr .6. 2. g. 2 a
. cr
o
= 5q C 7 ge 2 a
0 2 cr08 °
0.
5 o. 0
Ft;
alopathysyndrome(PRES)with potentiallysevere

a
ti LTc' 5 0 0 ,,,,.
cam .+,
C ri5
-O
' B
a gt
a. , ,, r
o co
1 4k E. .g °q3
C 0 0
0.
2. 0 ,. -g........
. r.r % R. g• 2' * o ,,,i 0
-, ,-, 5. 5

as
8 o. D 0 a 0
(' Ps- 4
4 g• `86 4"'
a 'g. '4fsi
t 0 = o. 0 0 s' 170 1,1
o.-6 ..,, .p p N 0 c
O
e,
5 H.
f2.
0 0
...,
m= .A. -1:
"
, s• '8 4 ec".
Iii, vs' i.,
,, <,, 4 ,....
4 c w to
a. 0
.1 0 cctc:.
0. ..Z
' 0 a.
= 0.,
0'. 1:2, g. 0 0 5
O -. 2 B
a 431° ii‘81.
aq moils (sisal lepigoicups.

5 o 5 5 a. cr a N N
a.
Q. o cr aCD r. cr
0 ,-,"' . !..e' C' 0
(0. 5 E
, E.
CD op., c ss. ,,, cu 8 c" 0 o ••'.0
".' rt?
"--
ce,
re cr
8 a
5. a 0
00 0a . c c. 2
x ','' 30 a- = a
s• AD 0 5 0 5. C `.<
0 t a 7'. IM. C' 0 a' - Cl
8 0 ‘<
a. co a _ 5.. a' 2 a
C Cl. iT
3
El. 3 o ,,, g g. a
I"' -a ... ":3 4 eg . g .. • •=1 g 5
. 3
Is*
... '+' 5 so.
= "'
01, 0.•• 0
a0
0 O 0
0
0 ?-4. 0 f
"1
, 2. 2
co,
4, .
0• 0* a
....
< o
'C3 o_
9 g = . r 2
04,
'' CD
s• ..•
o 65 ,,,. 5 ,-.
0 0--• a 7 fril C3•• P CD
CD

6-)
c, --
,,, _. . ,, . . . 8 ...g)
,, -0 9„s• 8 , et n 0
awarpurfs opuavin andiotuavii

o 0 -o °
muckipuAs deal AnimdeD

50. N. g•
.1315135BAO!pJED

0 Ca
. a
anti-seizuretherapy, if PRES develops duringtherapy.

0. 0 c
c '2 .0
- ii,
2 . 0 a =°: . 0
0 0 2.,
c c ero
o.
0
.., , .-.°-§ 3 g g k,
g -_,.. j. ff s s. Ug i 7,.. 0 FF: 2 3 L'
gg 0. s' ..;,-: oQ
cro & 5. cr.a a 5 c = X
0
tTi .- - 12 ,.. cr 12 g- a
,.., cn = .-I
•:e" C' 5 $ a i F R2 Ba
0. -a = = a
0
0
9
8. 8.....= C. f. a a- 03 !..
ro
'',.
a. G' 'FA 8 a
on i s' 5. 0 cu E,
0 0M
•-4, cc 8 ro. =
a 0. -A =a 0CZ 5
0
0 A=
0
gr 03OCI.
4
-0
ap, a 2 g g,
2 aCA
a a• •
0 cr)
a

Tx.
8
-a0 0 .. :54
c
co,
8 c.
gR..
0. <,
CD c '8 = ,.„
-• 8 8
0c- 0
. g'•
0a 0 g
at O. 7 7 ...0
0
5'
7
73 0 3- 0
2. LC
,. =.
.7,.
G
< 5 8 ag c Ci
0.
(I 8/--, 0 .',3 4' 0. ag,F• 0 trQ a .6.
a cn. pa
an
a .0 ,-7 0> .-o
F 'TcI
'
g g LI) 0 c730.. ..,
0 ,
g. C6
7,,
co '1:1 FD. N. n a
0 a .
§ 09. 7'. c'' a g 0 0 < g 0 sr = =
1-4 22
< el 8 = , .3 •tie 5
a- a 8 2' ii ct.‘•
4 ri va4 1.0
5 K)
FD.
,..,. .....
8. r'. i. P ''-'-
-o 07. §'
= =0g a. a. tr r1. a
C= =
CID
= - ‘;4 6. : K
N.1
1.. :... ,..< a a 0
x r•-•
n 0cr...g. $ •?,- Ng- 7 P, <.-- O.,. 7, = 00 = e
s- N• a
.1:a -1-,-g. g• g, a C71. 7:1. 0. 0
. g. „ C. 0 ,.,
-o . 3
0.
pnowyew enueurAqpasvtall

'. a 3 2
ri' g R_ 15.0 1 a•
,.;.. i
s °za n
n
o E
7 =5 .: : a
cr.,
,A7 .s. a. -a
.a =. a <.,
6 a.cr.
0, A 5 a "
a 8
05; ,--; .., a- a 0
a _..
_ 0 .• r,.... . a 2 .‹.
g g. 0. _
E.- <CD 8
8 5 a g:'• ,... .,0 0
=,, 0- ,..,.. tn.
P E. ••• ..g0P
Q.5
CD = in
7 •-• • TS 0. N .<250mc• CA P 0.
co a o.
. .9 ac. 11
...§ 0 a § 0- I
.. c° •-‹ T (9
aa 8 -i sr c .-(. -0.
g a
c ' 5.11 g c; "8
g g g•
„ . 4, . 0 0 ,P,
.juE.) 1, a .
"a.
0 "1
0 F. a g A . e• 5."
0 0 p 2. 0. a 3 0 '-7 F. 5'
 6.. (-)

Gemcitabine Ebewe10 mg/ml 200

moco,„ 0
!
s,-,, 0
O Est
..2. 5.•• 'a. 5 8 = 0. .(..., 0-is .?. 4 : •f,5. f,-.•M
g F.;
5 . ..... C) - 2 -a 3 , ,...
e. 5 8. " 5
0 = o-f 5
'7' 2 C)

Interactionwith otherme
' n ' 2
3) f-rf X co :0•
.. -s e• 8 ° 0 g r, o
o. us o O. a.., 2 •••4, g ce5 D ET A.
C) 1
o. - 67.
oo
8 5'<
" 2_vo . 8
. s>
, „
0 a E- 0 . ..... ..C.f. 0.

o . = a2 0 cif - 0. i0) i a 5. a o
M
°0 M: ac L ° I. _ ..... (2.,
'''
<• P ,....
Cp ff...
to) 7 .-.•
f-i .., 0
2., ? . 8 il' 8 0
5. ••:7 5 0 as? ga s'<e4 Cr CD fa CD N. 3
tmoo
eZ _. - " o•'
'''
g
CD ^'• 2 o
2
0 < CD :-., -•
5 ....
0
.
K
,-, = "'c, -= 5 .9, 0. 855
a. g e .... 1
7- •+.

m 0'S- a•-0• E
Ca
5
= „,-•a' c9, '-< "
.‘0 o ,"5•: 6 5. (COD
0. IA •-• 9
s ov E. .2,, .....1 O
cr ,. 8 0•;:
S :-CD.
zo 0 s, ,a s.
a..., R E a 0 8 •
o . 0 '-g o Q0 ; 54' g
= § g- 5-'
cr so
a
_ . 0> -•
-<.
Co
CD
5' 0* s 0- C. = 0 5o
0 5. P 41 44 (•T
2 g- ir• " §; M
---= a
o. 5' F, 8 - o. - g •."
(z.g uo9ons ans) pawl
CD co
- , a. ,. , cr g g.
O- 0 ,.-....s
8 a g 0
c 05 N (1>
0. 9- g
rs .a- 5 n 8i •-,
f.
0 CD 0. 11,
co 5 ,,,•• • 5 D
-.• 0 .0 0 cr CC
8Ro,c40. 170 < c,
3
233:053
a 2 g ..g a• 0 o g tz. 0,9,, 0 0 ••Z 0 -. ,-, 2.
a - CM...7.-
-- 5 2-
CLI
5- g cli 0 .9- w CI? 3. 2. 0: c. N
5 0 g o g8

Tetn lad wmpos &tutu

5. CR)

pnowtiew enueurAgpasInaH
.-T q
. 3 3' -o
°' ,-,.
''' 6' 3
o 0 (it 5,,, es;.'

Alinnuassa Les el st imp Imn.

`.< P 7.'
8 3' 3
g cr 0 a 5r5 e+ 5
CD -• a
c 0. g a' go 0.
o §: 0 5' 2, 0 a .. ..'
2
.3. o F
° _ CIO ..1
.
o :
CD < f3
5 50 5. 0N •-, ;....• cn
a ,.. . 5. a. 0 M; 8 n. ,"2 cr (5' '''''
‘z
" 5 0....--. so
Cr. ° 0. cp C4 5 • g 0 u, .
,•zt').•. a8•-':• n
a i 2
O s a -, a .
CD .0CC> ,
os .••••• CD =• CI °) g
‘< "
cr o o "
CO Z3.

;C)3
co .0 0 fl ' CD
a ..a o ••. .0 .<
so 2 0 CD 0
g• O0.
z 0 2. r. ?...,. 0. 0 .0 .-, E (
.' 5} co
r a 0.: a g
?. 9, 4, !-^ =•
3 N N ..0 .C.,', ,••Z ..., .....
a 0 •:-. P- ° 2 iz R.

D, . a 3 oL 00 (,,,
.< (2, z 6)
3ueu2aid `Antipaaj 91

0 ci,......,
....0 p 9.00.0 0
7

8 g a 8 Iw< 0 CD .-. ,. 0CD,,„0.

4. i r., x. :
a G. CD M "0 0.• CD 7. 0
CP ,fn 'I' ."' 0 0 .... 0 '5'
,' 0 5 o z-. N 5 ‘.0 L, o 5. cu LO,

8- z 5 s4 A Al Cp. CD 0 . Vo 5 = z g‘ .cL.
'4 •••••••
..< .6 o 5. 4 8 a gg E).•
1
f. q
'm
a' •• f:I.
o: a 7,• 0 a ..I
0. s 0 0 s es '
.-o 0 0 ...
,.. .."
.
et. R gagz =• - 0 . 5' ._. - ‘-< ug A.
3
.rs -is
-
a ..., 0
0 pt .A 2 ....... . ... i g"
ti
.CD 0 co' ,o, 5 a • '< _ 5:
. s g .-L• .,L,.. c. a gi
0. .4 0. 5 F ''. 0
f-i tro a ..
ro a;
a .- 0-
g.• 2,..2c
0
N • 0.
stpse
CD
: q, : ) 0
g a- .a
., i 1
0 0 . 1.-
2 (;)
R. ';'
N co a 2. . .... g 4 ;
5 3R„ it... ,..„
,
..... 0
.3 g •-"<- 0
. 0. a L CO 00
(5. .- =
= g 0 cm co 0m ...4v
0 11.-
5 2 °8 - g. .....z. i. D.I . : 1 1 ci g A. al
^ 4 2• 5. 1
,?,,t'
0
i
H E2. L'''.
....I' m 'o6' R., = CD = F.1 '..
5
,..43 g.- .4, 5 " 0 7

o
o 2: 0
5. .-
0
,, 0
5. 0 o ss co
9
cr ci
ig .. E• '0
' '' B 01 ::.,... crQ
(0 8 E
.
a> a r„.. ...., (I! 11 c o
5 ! :):" :
8 .
8 a: 5 a' ••••-t• RC. 2 ...
,. 0. = ... , , • 0

1- <2'
.e . 7'.ag•• 84'
.. o
P • • ., a. 0 ° '-‹ + qg 8
o, . c 0 I ,,' . 0
5 5.• 0 00 .. •54 ''''
5'. a g = opc, 0
z =
2 .-. 3' cg li 3 • 3' 2 - so
;11.
o 10, . - , ‘
o
g. o P., *.ig 5 os
p z..
7 u" •• 0 <a E•
5 ..7, ,L, 0 o
. -• qj • a 3
n •.!=;! ..L• N a
g 5 w N a •
,-.i . ..,
S
4 o ;-.
-. c6 te, 5. i•:,

5 E.
i •-• cn
e' IX g
0 0 0.. a si -.... .8
CD
C. 0- a, 0 ..?,
N 2.CD
CD
co ...) 5 ,..< ° a ."
4.....
c.. 5-
9. i. 04
.
.... : 6
0
., VII 3 i .4
N
^ 2. CT a. ti
CD 8
rit 8 E 0 5' ‘41, 0 0
.... 0 0 0 1:' ro a: 2,
= -5 N.Oc.,. 0 8 = % i<
P" 0. Cr f-> 0 0 0 •.< 0. 0 ov 3 a 6
-
.-• o
• •"' _.,
= 4
a 2, . cr 5 , 8-,oss 0 z ,-. 5 : . >
1 0 CD
0 ,-.... cr n• 0.• 5- 0 ,,,
•!. i ...7
pnowyew eNueurAppasyke8

CD 4-1.s<
.,
c. g o °
"
c91(.,„ . CD.••DD7
CD 7 ...-..
13
O. g.DT:
0. i oto, C1
. •-•
0. _,
.-..

0., a R
F7 2
o v;
0 , 0
0 _ ,,0 0, . g 3. 0
m. 5 8 •-•
n 0> o-
c,.-, R a g
g• g
' 0. c 0, 0 0 o 5 '"'
0 „i
n> ca• = a
`mtuatsAs Jo Isp alp m

80 .9• f1Qg' g. 0 to o• 8.
5 r
t t 5'
0 CD , 2 '". 5 -,
g Cf0 "CS 3. V) 2 qe. 2, ...-. CD S Fr =I. .r.,.
.• S
-2 a . .... 2 . Von CD ag
r': 45
-• -5
Q. )-7 ''' X a
•-• -. a
13 .'"
0
a . cra •-• F. a- 8' N , , o,,..,
oo
_.. g , •
me • 0,
, Q. 0 o
=o ..,,P_ •-‹ g a : '.-:.1... as
- 0 g, a E. 0
62 5, i't
a 1:, '
c0 . a ! i

• 02g '' ii) o0_ °- < cr 0

2. 0 ,
5 ,,.,1 ,,a
Sa o, g 0- f- • W . co
n ''< L
.)
a G,- g* 0
8 ..s
CD
0g0 -t o .coa0 0 g CO
Sa.- g. 0.
F
a 0 Cs i:5. to/' E. 0,
1-., O. CD 0 ..1 co . 0.
 • 8 724 z a O.

Mop /v1.0 j pof t41,9

• 0 .-..,..0 ,,.• ...
0-

snip uc2.10 tuatsAs

SUO9EI SEJU! pUE SUOpPEJUI
= ... e -0 = ,., -
bp o o
0 •-0• --, — c
9 -c, g.
5 o ,..J
il 'Pe g .,,
a
'• e'
0- Q' °
g ° sg5g
22
=to, 0
F>
a• -0" 9 .A,
=o
5 t•
5 O < g ‘,0 P.; 2

spajja alqsa!saptia
° 2

Effectsonabilityto driveandusemachi nes

CP 0 0 CT c. O .
0, .e
p.) c
v, o co 5 ?2,. K , * ..-. 0
. =* E. £4 B 5 oc, g . _0 t 8 c•3 .7
ao. 0 s• a • a r, s
C tr°
g 0, 9
„.., a § A •ii,
.--,
-- '-- ,•••• .* t" • B g -
a a cr 0 -0a,
..u. 0- •:. — a E. 5 71;
c F,,- 03 .... .1. — 0a
tr. 2
• 0 CP
0
0 CD ' m• cr 0
g •-'0 :'-'
Pi
o
...., 070' co Q. 5- ‘.7
' 0 p
r, CD
`..< 0 0a na — o •••••
9c —• 2 •-•
N
a 5x
0
0 R -,N 0IA
0
Et
5. '.. ..g . 0
a — .0 9. g
a
7,• 00 -
. 0 ...-,
E
•-i
. Pi IV < F 0.
O 0' <
,.
= ,.. E ,,, ...›4
.. . g b,
ge 6'
6
DT p ....,
I:6 ;1Q ..Z3 0....51.co..<g0 50-<c O
ii. co
(0 a9 CD
1 ...< .=:: 0 • 14.
a
o 5 s A ''''
c •9 0 ir 2
=
O
z n R. g ,-- tr._ F./
2uidnoi2 tcouonbaid

O 0 A CD °
,,- • 9 iT a' 2 R- c
O _ 0a
O 0
.0
0 =
CO
8 0 3 CD
Fp 0 O CP
a =
,
a
n —
C) co cr
O cy E c.
lam ui patuasaidais

5. A.
a .-. 9 w
o 0
co o c a0 rr,
0' o

pnowyetu enuew:AqpasIna8
aw 17i a
c•l' 5:c:cf9 1o
5
=
:0
a0 tz co
. tro
w t•
cr' eq.
o
a. ti
,_,0 o
O 9'
.-t"
o <,‘
0. a <
g
co
• • PO
•
•0-., _— (70 • fD
CD. 3. z 0
`0 1
0
8 g. " CD
• 8 o 9.. CD
O. ,
,0 0
a 5.
as 5. P.
cro . o
0
• 3 5. C a
Cardiac disorders

Nervoussystem disorders

Metabolismand nutritiondisorders

Immunesystem disorders

SystemOrgan Class
I7,
6
o
c..
G.
-<"
a
.*
a-
so
CC
N
..<
•,
5"
B
o.
H'
t41

g
0.
0
N
,

;
Rare

Uncommon

agile.
Very

Uncomfnont

Common

Very rare

Common
Veryrare

(secsection 4.2 and 4.4)

moderateand mostlyaffectsthegranulocytecount
Bone-marrowsuppression isusuallymild to

Verycommon
.

Frequencygrouping
1

.• e"
•.. 7
Myocardial infarct

supraventricular innature
Heart failure

Arrhythmias,

syndrome(seesection 4.4)

Cerebrokascularaccident

SofftnOlccr

Thromboticmicroangiopathy
Thrombocytosis

Thrombocytopaeni a
Febrileneutropaenia

Anaemia

Lcucopaenia(Neutropaenia Grade 3 =

Sepsis
nsomnia-,

19.3 %; Grade 4= 6 %).

_
steriorreversiblecncephalopathy

aphylactoid reaction
ache..
2 •

Pi'
..

pnouitiew eNuew:Acipasytav
predominantly

,
SystemOrganClass Frequencygrouping SystemOrgan Class Frequencygrouping
Vascular disorders Rare Uncommon
Clinicalsignsofperipheral vasculitisand Serious hepatotoxicity,including liver
gangrene failureand death
Hypotension Rare
Veryrare
Increased gamma-glutamyl transferasc
Ca. ill . leak sndrome(seesection 4.4) (GGT)
'

.
.
•S'
a s'.

cl.

2:

0C.
5 B^
0H' r..0

Verycommon
0
2

„-,
..`?

S'
u)

o.
E

:19

<
pc-

la.
g.,

6'
'._
0L.g

-,
g
s
8

„so 0-- 5
M

(1.

*> 2
i• • q
i=i,

Dyspnoea—usuallymild and passesrapidly

= .= til

m.

a
r
g
=

0
Eo
,..<
withouttreatment
Common

0
o

o=
Cough
Rhinitis

0m-.
c") ';"
5-
0 • •
Uncommon

5.
2
X
• t4tAitp
. ne 'Os(seesection 4.4)
erde ildand transient

o 3.
o 1.
=•

n. o•
0
6

m =
C sn
a irg
‘

era
i
ayrequRTarentcor.treatment

F
o k
...r

v,
......, ..,N

H
.o

=
1:32
e

i
16

tz.. a

Z::1.
...,,
-,.
• • 45. • •

=
Pulmon ema •-
A Attu! • piratoryteiess-1), drome(see

.- . • '
r3:7
% _..,
.
. on 4.4 ,

'.
..„ .
Gastrointestinal disorders `Ve )' . 'm on \

5'
° '-3

cn n
o

0 ,*
3y
0. a
a
SP
sVomiting " ,

• ..-ok.
°
Z
=
ea 0

ti.
'
144.6 .0 4. 3 0

1
Cornino-

01

-^:
o
Musculoskeletaland connectiveti .1 u9teilf
000f
• • • • •• Diarrhoea
• • ••• • • •
disorders ..
Stomatitisand ulcerationof themouth Back pain
Constipation Myalgia
Veryrare Renal andurinary disorders Verycommon
Ischaemiccolitis Haematuria
Hepatobiliary disorders Verycommon Mildproteinuria
Uncommon
Elevationof livertransaminases(AST and
ALT)andalkalinephosphatase Renal failure(seesection 4.4)
Common
Hemolyticuremicsyndrome(seesection
4.4)
Increasedbilirubin General disordersandadministration Verycommon
 o

0
W.1

0.

0.
8

0
-o
-o

0. Flt

3
w
GI
>

3 PO
SystemOrganClass Frequencygrouping Grade 3 and 4Adverse Events
0
co .

0.
-....
5
=
0
n

Influenza-likesymptoms-themost
co,

Paclitaxelversusgemcitabinepluspaclitaxel
commonsymptomsarc fever, headache,
chills,myalgia,astheniaandanorexia. Number(%)ofPatients
Cough,rhinitis,malaise,perspirationand

Av
0,

0p
( )I 0
sleeping difficulties havealso been

N
,..0
paclitaxel arm(N=262)
reported . I__Grade 3 l_ctade 4 1 Grade 3 1 Grade 4
Oedema/peripheraloedema-including facial Laboratory
oedema. Oedema isusuallyreversibleafter Anaemia F

p
LA

.......

co .-.. ...
.-- C3 .--.

AJ la LA
4/ LA LA
,......

...-, ...,....-..
a

•la .....
....

•
stoppingtreatment

..0
17

.--. C7
4-4

=
loo
a
a

DO

,•-• '
Common

4'
..
I,)

*
I Neutropaenia

b.,
r'.

',.)
..--,

*
(A

i...)
..,
a......
I Non-laboratory
Fever

•00,,
Febrileneutropaenia 3 (1.2)

CD C) C> .--, C>

S> C.
a-
gn N
LA la
......

..ta
Asthenia

'

•
•

N CA Lo
:".....13 00 cr, i.4

C>

""--.‘ as)
L..,e•-..
CA 00 ...
Q g
Chills

0.

IV '''''`
LA •Cos, .
Rare Motorneuropathy

'.(..la3.8
la. ...--,
1

.l.
..._....,..,
1 Sensoryneuropathy

...."'
..-..
Injectionsitereactions-mainlymi ld in
. 6•441Ee
Injury,poisoning,and procedural
complications
T0314,
-
ere-kgs*L
• v to ity(seesection 4.5) Combinationuseinbladdercan
Radia nrec
.Y%

ea%
91

Grade 3 and 4 Adve • iftAr. 44144%* I

r."

;
N
.
0. yar PI
•
-4.
G

MVAC versus Gec 1pluscisplati70>

a
g 141 e2
F

s. 9, 9.
t

=ag
1 'Jr

- .4 •.0. 3
a.

Nunkbsr,(261lof Patients
U

n
a 0
,--

°yC 00
f

11...
VAC

41,S
V. -- emcitabineplus

n
(methotreicate, splatinarm

H
E
vinbl4stine, 2 .1
/ (N=200)
• • ••• • doxorubicinangLO
cisplatin). "-
" 1 I li
0
r

0.
Grade 4

W
1 Grade 4
I Laboratory
N..
..

... L4
Anaemia

LA I:7
...-, ......

A.> 17j
CA

la

-4
T.•
. [
47(24)

-.4 ........
t...>

cr

1
:s.

.....‘
,-...„.
8
3

,_,
tit

....

U
43

Ka
=

LA
1.:3
....
Non-laboratory

..., ..... ..-, ....,

2Z.
Nauseaand vomiting

LO .. .., l,..)

C.

s.7.• a...a.,
e, - 0 e,
1 3(2) 1 44(22)

LO LA ...4
1

,
=

N AO.
Er CV.

00 C: '.....
= 8

CO .-. ...

-• N ..- 4:3
11 ...R ....- '
0
v

............
5

IS ....-...
4,

•
1 Stomatitis 1

.......
cn
 E.. 0 0-3 44. o cc)

So-AoS•qmatioluTpg@ia3uaavid

Combinationuseinovariancancer
3 X "
O T* 5 0 0

Non-laboratory

Laboratory
o. 2• 5 • CD

CarboplatinversusGemcitabinepluscarboplatin

Grade3and 4 AdverseEvents
s?'r. 1%. eo

Pharmacodynamicproperties

PHAR MACOLOGICAL PROPERTIES

m. ,
... 5'
▪ Po

Neutropaenia
Infectionwithout
Febrileneutropaenia
Haemorrhage

Thrombocytopaenia
Neutropaenia
Anaemia
O
o. ,•< , a O
,CD < 9.
8• °
co
=
."
0 0-,,CCD-j:
0
co co 0 •••t•
C= o
10 co rn 0
...,
0
,75", • •
F., ugE .°
0, CD
,

I Grade 3

I Number(%)of Patients
CD c>
.7 co, cs.
:5 .B. c> -
- ,--

(N=174)
Carboplatinarm
CC
D 0
C
.1 .t..., Co
c< so co
co
.to 66 f:., 8 =, t!...,
••-g, L..) ,0 N...."
..... ......
CD
g •• 6 a
o 5 9 0
0 ...., 3. CD 0 0 1--. ts.) t....) ia

Grade 4
co
0 v 0, i,-; 00 0 c> -, .-. 'is.)
a Po ••-•• 9'
Cr 6 6 ,.....•
6 b, ,....,.....,•-•
• -• i...1
EP, g• a ........• ....,
N CD 0

[ 73(41.7)
0 i ---•• t..1 t.4 oo t.n 1....) c.)

(N=175)
carboplatinarm
Gemcitabineplus
4, c..„) ,0
O ND 2 C5 e, .•••••
.:9
... r'. :-. "4",..". 1;3 :3
'E
Cr
• CD 0..
s.
'7.: 19 OD 6
6 s..., i...)
ND CD
1..,.)
o o ..... ,....• ,.-.0
5 &'-- cg-
S .N

I Grade 4
... .", "Ts s. 0 CC, t." s0
..-, co p ,-, .--, o, .-..
0, •---,
,..1 66 !-'' -L• LA
a <0 c'
0 .......-• ,.. g•••) '.-.
0.. s• .0 o .....• ......• pc .....-
S
• m. o. to. ga
,tr,
' • el.Ce...
= ,m-, a•
o
7 --'
.0 Co =0
• 430
•

▪.1 ., (1 Co CD
.o ,g- CD
to 5 0 CD
.-,a Cr a CrCO
Co '.-...
... Cr" CD
0 0 co 8 r•

0. a -s 5 8 $7 Er -0 0. 00cc ac- "

c..,
sinotunt asnotu jo
Imps jo utsmegoaliq

0_

CODEEITI:0P03 DIV
Cytotoxicactivity incell cultures

Pharmacotherapeuticgroup:pyrimidineanalogues
5' 5' Z ° g i• CD C. CD 0 0
• 0 =
CD CD
rn'
,6
T
0" ...
(). .... 15" Ti
0
^T
CD Cr
T`• E. 0 o• -0. • 0 cr
., go 's. 0 ,.....• go F-L 0'
53 Z' 2. 0 0 a .cr =
2 .0"!a•
0 0g, .8 8 5 0
a
IDD co 3 Pr
5 ID. o ==>
z .-. o-
g ,i la. 9 0- o• c„ 7', 0
g § RS§ g
^ E 8 o' 5.o g, .
pNj
g
to Al
E a •a5• ,.°7,3a. Fi,• g -, 3= '93
A'
(4, g ° e. 0 „Pr 2 s' 2
o. 0 q ° r." ("75' 7..ii
= r. E.
o. •••••
o . r5' 04 0, Ls R E. .N-.e..
o a. 0 .C2.
- -i73c-.iz s
0 (.0 "g-
...., B g '4.
▪
g
Et0:-gq 0
5 00
,., IFT. ... 0
3. ox
rn .-,.
0. 47',4 ,2, .0co 0
o '0
-0
5 0- 5 ,•-• cr
P 0 e• F,' F,',
.. 0
. . .- .
1

g 0.S4
5 0 94
3o
.. •O 0,
0
0 0 tzt F'
D
O
d CD
5. Z ° O ‘5
:-. R
C' 5 K.)
00 C.c,
0 a 0 OP
• 8 g O g0 5'
8e cr
5. 74 se.
▪43, m ogt o 0 Ef 5. 51 n
CI , 1••)
P- a. E. t, 0. ,
CD
E. . e p?
c) 2 °

" cr. E4
. 6 ... (De, a• g.
ota g' '4 ‘Z
... o 0 a. 0 .... ° 0 tE 0 g '-cl 0- a.
5m O g ° 0 (D
O
I-1 3
•-• .6 0
,-.. ....,
go. 6
• .11 ..
4 ....
0,-
0
>1. a '3 7'
5' cr
" 3 5.
CD
0-
cr
A -, = co6
-1
cc> - 0 q• @ p> a. g •-6 ,..
.a: .0 tr-',4 ,.,,, ,. 3
•
.7'
cr °-co
5 5.• og
.a 0 a ", f-, *
5. 01 12. o o. 5o do .o
" 5 9
TI, CD Dr g
O. 0 e. ig 3
Er.3§. 0 0" rg 0. 0
8 .• s 0. m. - o-
(7) 8 g. E. @ s' et ., cO g0 C5iaa'
.60..,-.... ,...
° 5' o
co. S. >Z CD
7 g
p
° Z =• - s< cp, '0 .4 .
a... „...
•10
ct Ca. clo .
5' •.1 . 2 _§..
.-s,§,6 rOr..0):1 g a '
zz (t , - = 4- E
c, -0
0- o. 2E°C 5. E. =
a 0 ., 3
CD
11 7, 5' 2, co A S' CD K CD
E. 9 Po- a2 ‘7,' 2, i 8
 DWOUpI DJUV111240
0 E 5 8 Er 13 =-0 ,

Inboth studies itwasfound thattolerabilitywassimilarinthetwotreatmentarms.

,‘, o" g dwo3. vo co ,2-0=0.05. ..1, 0-..m
0 0 cC6m> <0

daourro Sun/ 11a. noun uoN

Z Er c A5. („„
`- g F... ' 0 e --9_.00 s; a A, 00 a -0 n .... ..,
abg02.-, !.,' cr 0 c0a
a t.9 E a to 0 E 2 ' '
8- 2 '•Z'-
8 g 13 c..,
al. 2 . , .-1..
.., t- F. 4 : cl • '" -. ,...
.. g ,„,• e,
a os. 05.
("7,* 0 (.4.• n
cr
g' 4 ,
A^•` • CIA 3
Al

"9- °' s 5' E.,, E E P F). 3 (7, 0

c 3 ‘7,.
a= 0 9- 0
K 9',.R.,m°- glq=m5 o c§ '''') to o 0. 2 ao) c) =
P.-00"gg 5 cre a cr lg. x on ..to•
R "..° 5 0 5-
gg% 13 54 <,
. EL' 0. qi 6* a- ° g 2 ...
a- f71-
• a5.8.=
13
a g '`-'• ' a; 0. 1:0'r .. N •
•0 -
00 oo fa g 0 m 5 6.
Fi. 00 o. .<0-
• (IQ -t .o.-••
...e
a Et S. a" Z'°, 7.... =0 7 a.- "8 --• ' roQ. 0
R 0"
o , o = 2, 0 .9. 0 n = 0 to ,a, e.. 0
•0 7 'a. c °8',a
.61. n G. a CD
E. aToi 6 .73 'lg''
-' 7L•.'' 5 ' il - i 'T " A.
g: .6 0- Ti. 54 V; ..°. ca
c iv =. 0z g? 3' -0a ,,,7'
. •,-..-,
Os =-.0,,...
aCo111 .Ps o,< sr0 -0
. . 2 6-..
....,
..
(3,
ci g. -0 (7
0. , 0ve, ....3
‹.:..' C.
aa
- 0 p' -.,..,
a c.
$ 5 ,.
, o" g- 0
c. 5 a o
0 °`• % -
l 0- :to,. =.0 0 a.
cr.-.4 ,._ 0„ ow 5€ a F 4 ° e
u, col Cr
0 e 0 23 .,...... 5.
0• ..00;
.....,_ 0., ,:., I*: = , `P 0 II -0 ? *
tg -•
.....
Fp.., O. 0 c..... F'D LI,
O 0 .0 ,-.5
.., ....;. av,. 5 e
.E a 0 .$1 0.
6 c) F:
voo 2 mr o 8. , ,,,.• *
ir g ‘7. W Lo iv
- b.) o
= < X. :-2,..‹ 0 2
41:0 ...., = E 2>a8
.
0 0B > A, 0. Z
.„ E° ::,P....1 1:!?
-0
9 0 i.o.o
i..) v, 5 tp CA < W 0 0 m 0

pnowtow eNuew:Aqpawati
'
5 5 Os '-< a F6
2 ... tro 2 2- • c0
p - m o
1 .W .1'' 2 . ....,.., = 7.7 < a 0 ... ,...,
-,
. Io Sr- :•4 A - ct. ., Aft CL 6 m 1; -
9 5 s VIg ,,, a
6 5 43 6 6 0? to g oa 0 0 „,g ol
CK ; '
21
. C ? -,, -
iy-
5, ; 65
'0 4,a „, 8z
. < 1', • ..., i
. E a g.
'6c-00 C.
r.' a co EE =0-0 a 8
4°.6 '!,1
;1272'!11 0
g 517 3 co. VP> 'R 2 '' 2
q0o..,. P .., g ff 2 • e
0 .e.o, • 0. ,,, 9 •5;• •
4' ti 1 a z 8„mm'wg1 4 2 5 b •-= 3 0
2 S P ,8 a. ..-:._ 1...). A:.
g:Aplap g P o --- a 5
• t4..F i 0 1 :::
: If.
a 8 all
ru E; g t
0. .... 2
,-. 13 'Z.
0
4 4' > el Ao a- ,r-,,z- g. LA Pc0.A) (-I.
S 1.r.
. ).
, =.. gf. .:
''.
0 'a

'3,7 8 5' j
0 ca 5 4" '.° „. > 5 ;I:P tt, 7t .; 6.-1 'a * `A 00 "z *. 7 6 GI
Po- 5 m. A '5 * 1.7, 6' = '6 -o o- a.=
LSn...0 6. a g L. g- „, cr .'45.'-'c
o a-§60cOgato .... - o 0 2. o . es;
E r' a a g Er ..., ,-=
es -,,, E ,. E E on *".. 2. a no •-• S „....
-• 2o
- ..o ° .2 .-, •-, g al
0 cr
radoad altauPl omnumid

.. = a g
a . „ ...- 5-
' g X
CD 'El a 9 13 = 7cD o .-. _.
Flg-E.,t_i
•
-• - . 7 0 OC i.,' 5.f -00 O. 0U.78
-0-
• a 0 P ti '.°
. ..,.. a g Q. g 2 r, 9 ° a
o E - . •." . 0 4.• _' 0 coo 0 0 tz. 0,,
CD 1 '' 2 2 8 0. 3
, eg...7.3g.(1.a
5' 0... = g 9
'e... .-, 8 W.' N Q. b,77: 3 g- 5% -0 , . . ,2. , =. c • 1 . .57 • pr I :1;
.P.. Z c•• 0 =b..) °- I? 00 o c. =
2 a ......a _„
:"4 5: -•- a 5. 0 Non
G) -4 7 E .-.. cr
0 . ,,,,g toto 7D'
a. if c, „ .-
8 0, 9' • a - kt a 2 0 oct
co' 9. vo go' "+ 0
cr is.) . 7 - ; s. c.
<c o CO V 2 c° A, g :=_.: e 74
•' 0
g= a 0 a -. < .c, .
‘ .9 -
.1 i 2 1 ,, . 6. .1 .
a=
. -. '9 E. c 9 Ei.
. ..., co ..°
z. -ci "' oo P P.:
- ° 0 F fa'
4 cq
F5- - -. „en
, to ao t4
,
,ar*I,R I , 7ii: ,Di -g
a e. E.2 '0 '0
62- 6- 8Y--- „....3
7
64 1: 0. . . .0i• co
.59 .2.
0 '-'-'• 8 S•
II 'F, 8 E. R c8 § a" cr
•-.. " : i <
n• 1. A,
O
C.n ....• 'eA 2 . A o
S•
7
0
Co ..,... a 5 • 5' P
- 4 •-•
00 - 5 gr•....
- 0 a
,4 . 0 cr 5 . 05 :
:,.,
1
,.,., 40 3 p. - cm 9
-... -..
? 4=..) a 2. 'iv .0 00 40
b 0 -.
.., ......
"4 ":1 9.' Z to
,..

e .... a' R `1: 2. pg. g. 7'. 57 •••• ma 4 0 a" p t, - . a.

.
I A < 1
"o°‘ b. E.': s< =0= 5 <...
0m.... ....
--,e,- ,-,,- mmr „== m< 30
8. E' e? 0 .. it0 .s.4 . 0 , 06 6o la 0 x
m ,--'
- cl, 0 CI,
c= c= a >
''' °
O 0 N) ..,.O.m 73 2 ff 8 = F, .0
R CL g. ,
3o .fo. pp co .2. ,.., g. 6 g PT cl.
0 c-^ 0o00oo 0 (-) co 5. 8 2+.
priowyew eivueitEAqpas!nali

2 3. 0. ........ .....0 o ..< -

EL- R, (15151 OcrG•°"F.55'
S g. ._, 5 7* 2) tro 4.- a g• .- g a- 00 9 .c .:,<9..,0 3'•:
2 Er a 0 co --
0 -. o la .0 a i0,
Flg..›
* 0
a. . . .t,7 .
"6. o
5, .-.>
0 E' A g. '77;' tt. f se'.
• = R il; o5 (' .4. ,, g N
. ci. 0
cL s•g, r....)„,.., ,.F,s na
..-, F e. t2 R
,,...,z ,
.g - r ri o. ..0• -0 „,
N.) 0 a
tC. .-
t, 2 u ,,,, •58- .s.
i ---
vi
5' ce.. c •
Z 10
3- r.:
1-^ p B !..0 3 a P 9 A P 2. .,7., . ,,,
O t..) 0

sE 9 E w -. C1. 0.0, 001.

•-•• C) L4 0.5
o.00 W,
T0 e 0 ce
...I (I5 s....• ni.
- 0-
 0

U0r1UuuOisugilo!El
s. 17 •-i r-o, .-I I-I
,-, 0 2.
g = 3 w= -0
0
-, ti
7 eV
pj.). < . =
R O
cr 2 n. g 6
P t:t oto 9- -to • .5 `F c __. 0
3 O' co 7" 8 T„,•,'
°
-., a
8 9 0
cr g. :.I. O 0 Fa
5 • eo 3' 1-1, 0.
g 9 r co., a - .0 t`.? n ^y ° • 00. 2
. -0
0• "
.r,.....
3 2 „
:-if-4 n•
g 8 E- 2 4711.1'. 0 0. 0,-
g..,
gF„-
-0 c,
2' G. x 0. 4' 73
c
to O.) v, n ,,o
3. g
r., 8
C. '
- .
it 5; 4 `7
O - C/
-, A 8. co cra
1'2 g. .2 :71.
E a 3^ FD c 0. a
o a 0 a a>
O- 0 a - a P'
,0 C
or
s• C 0
N cr 0 - a.
G. 0. ..„.
0 .., SO 7
.0 c _. O w C
9. 23 a o $-03 V. 00 .1a.
o 0 t.)
5a
,..„ , .-0 4. g. E: rr. O 0.
3 0
▪ re 5 0 a.
0 ,-"Z' ,•4 G") a• - -04.
0. ,n 0- so 8
<
17.1 11
5. 5 ,o •
ex; o r- 3. 4' > E‘L
1.
• cm, 0 m ..., t...) a. 3.0 3 c 2
= .>3. 3 0 cr -• 2.
vs
‘2 a § •-• 3 32.• c
NI a 0 0
... a. '_,:
Q, g.. ,,,.. §: .s.
I-. 3 a 2• 0-
- ,e a • §F -0 3
c. . a o
.1.1 sa a g 2' 0 K 0
a 0 0 = a ,„ 0,,, i ,
e,
a • 0 .9- g 0.0
-. N c >
' E•
8 0.

leugAqpasvkati
a.- g §
• • n
< o. a e) 3 2" 0
O o ,..87,.
rir 4 0..
,,
-• cro
ct. g B 0 eo P. 0%
0 =a E 9: 1,0 E• 90
:
8
O
0
{., 2 C. ic7.). E
eT q- gO.
'
0.

pnowyew eft
0 01
=8
a 9
5‘ -1 5
... 0. "2 C. 00
cr 3 7. g
• P530 "6...6 ...
• 0 0 a =I
N 0 8 S' g F., •
0 r-•-• "I
0. a 5 9.
0. • 0 o '
0 ti,
• o. 0 -.o n

0
Tissue distribution: Extensive.

Meanvolumeof distributionof central compartment: 18 Vm2 (range 11 - 22 Vm2).

Formationof dFdU fromparentcompound: 91% -98%.

'I1V :uopioxa itreupn

'A3- '..•->. (3:

n
S 0 C g
ct. trs
1r7: 6
, a2 • tTi
.. Is. 3n
=3
Fo'
0
9,
0' . a4
tl R-
..
i:". r°
L0 0
H
0 y
3 0.
Co 00
3 ill

O
m)
'(: /-111/11?- 1at

pnouNew eivuew:Aqpawkau

..-:.1
0.
G 8
O
era m.
g
 oievAtip.L mmoov ummoS
suopoofm 103 iolaM
Sodium Hyd roxide(forpHadjustment)
.4 -o 3 .-3 . t...,

:uopnpp nun ajp Am.'s

Ni a' C: ,..,
5. 4 -• C.k--)N
;$ g w

SIIV111 1.111Vd 1V31.1.1133VIADI VIld

stualdpxa Jo tsn
CD
..... 0
•4 -• ,S, 3
CD et S g' 7
...., c
..1
..o.-...
R. L., 9" Q
E 9,
•-•., t!...,O
a g. 2 =*.
3 n' 5. 1 . c -...
3 .. 3 a
2. 3 g
2' o 0
.
Cr
5' ., fl.
it g
0 g. 8 c o, :..,.
.0
-- g • Fo
E. o toc 0 .,
O CL W . Cr'
CD
o
-, e. C. ,,,
CD a
°P.. .4 = .... a . 7-....
• .-''' g 3 st 5 a 0. 0' a
x.
a

3
e. 0
s•..... 0 0 ,,..: a
nct a ,.6
o "g= o. . a
3= • 7. 3. =
CD .-.
.P: g. 3- cr N ."' 7
O c4 ._ cm • cr,
q Er: 4c c
5*
•
O o
, to 5 9 c- o .,
2 3.
0
-rt
.. . .. g' .
-
• 0
0
G. 3 p("p 2 ▪0 6
- a.
g- 5 6
1
5' 4 0
c p0
g.
O
0, -8 E
5' 0 c -
0. g • 2. 0 0• ;=5. .0

pnotutiew ernie w:Aqpas!nal3

O
ar ,..
0 ...7.
. i. Crci
0 ...a.
O - .
E
co . a . a 0 CD
tn
0- 0
CD X .2 C
0r
0. 5 cr VI.
o. = 2 O0
0
•O o-.
-, coco P Bs., B w
''' C
ar
= ..0
--
., " r0. 00 7 a 3
O C .P. :.-
.. cr • 1
0 -
= ‘*.
a5= •
O
0- -A.
51 g 5
O, D 0
-
o c5 .., o. 9, ca
o -., z
0
-
0 0
1•3
a ''' 2I .Co,
g CO
CD
P. =
0
;
I ,i ., C
g g
P. P. a ,..
5 c 3
co 0

:alas nu pawedsV

no E.
6.5 Natureandcontentsof container
oq Aew soz!s loud lin tom

!A SItt!A1:Iw001/ w0 1

0- 0 0.• :73 Oo
•▪ no
00

! = ;1i- = - 4"
t3. ac 3 -o 5-
Specialprecautions forstorage

co 5,
= -.. .
o W 6,
2

P• 0 -3 " F? g P„
s co.
,
0 . .., 3...•
..., a
s DD
s' 2 n to
O=.
= a "
90 ,. . , C)
<-11
= 0. .
e• ,,3=.,
...,.
Cra
O cr T.. .
8 a ...Z
v. 0 0
co 0. .-.)
cn 0. ...
0 .-,
,.., 0 O
= C Cr,
O. -4.C .
0
c A c
a
g
a, N
no N c i-
A, ...I .c)
.0
.I.. o -, 91. gr -
•ct no0 ,,, .6 a;
.7 % 10.
N 8.
fluoropolymercoated halobutyl rubber

7 k.•
0 0
- 0. 8. 7
0 *40
a
pnowyew enti ew :Aqpasytall

" .--> •-:: a

O5 .
•
:15
c to
". 5
5
o: , co
o
5. 4.. ff
a
Q
O g

a
P.

0
O
 m
:
4 ro > u
7" u'
=" -k- 2 g . rA
C''' -3 3 2

Medicinalproductsubject toin
o-
A0
c ,-<
= 0 0 c. fa,
-„,
0 0 .?1, . K 4,
co at (..?,
.....
•-, 0 fro 0 t.2. -,
- g L'
„„ ,..,
CD = .7 ,--- .-1 0 F Y.

KOISIA311 30ai.Va
3 0
CO .
g g 74 '') 0 04 g a R.
-cs R n o p.
7 r''
,.. O. 8 •':•‘• . A, 9., 0
,-]
-a 3 a 11: a , c, -4.,,.,, o f
-F->a—-6' rg 0''' 0 ''', k\
6: -° 3.,<c'
P- 3 2 ..a ),..-,
C") a =, a B Be 8 ,,, .7 '3. ??
0 .... 0 0 -,- ,,, o Va

-i
0 g ce - ':',q '6' -
0. cA Ft.'" 5
a, F,.
. S
E
•-• r-r
133

= a .._...
0 — E o — 3. a
v.... N 6 vo 2
o
0 n
0
o
-, o 0 no
0 a.
a a. 5 oci 5. P E
>
g M
.5
<9 0
g a P. .= 0
•—, 0 -0
-a
.-3 FO .— " 0 . "7 `4
0 s a s. 0 — F, > 5
a 0 ca .'-
,
z a a- .-. g ° a -
......tO =.
0
-,. 0 .
-Z.
. 7 03 2
F
< o 0
0 sa a
. s• ...,S4'
0 -, A, a, ..4
r co el co a 57, 09
5 Kt
CI = on r P-, P = ti Z
tr3 o .:
:e 5 a- w G-
o. E tw _. S. 9- t,'
0 0
o-
0
0 "k4
5' 5 ,e) o
^ O.
cr , .., 1 k"
7, 5. st ,.., E. Er, a

pnowyew emiew:Aqpasina)j
-a a. -, 0
o
9, .S' . E cr -• 0
a
0
o 0 ,, 4
CA ,
0 a a-
'-9 CA
c C co
.9_. .
"9
S.
IT
.•< to, 2 ,..
s., E• F,
s a ea .
o
o.
-, '- •
a 5-
P .E
g
g
:6:: -•
5 0
5'
„P
.-3
0q
4
0.' =.•
0
p. , (9 5'
<0 .... (19
g ,(..4 0 ==
41-.
0ta
R, .<. 0.•
0